Silodosin Capsule
Product Images NDC 72162-2447

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 72162-2447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 01)

Chemical structure of silodosin depicted in a black line drawing showing detailed molecular connectivity corresponding to the active ingredient silodosin.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 02)

A line graph displaying silodosin concentration (ng/mL) over time (hours). The x-axis represents time from 0 to 24 hours, and the y-axis shows silodosin concentration up to 80 ng/mL. The graph shows an increase in concentration peaking around 2-4 hours, then gradually decreasing with error bars at each time point.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 03)

A line graph comparing the change from baseline in IPSS total score over time for Placebo and Silodosin Capsules 8 mg. The x-axis shows days (B, 3.5, 7, 14, 28, 84/LOCF), and the y-axis shows the change in score. Silodosin shows a greater reduction in score compared to Placebo throughout the timeline, with statistical significance indicated.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 04)

A line graph comparing change from baseline in IPSS total score over days between placebo and silodosin capsules 8 mg groups. The x-axis represents days from baseline to day 84/LOCF, and the y-axis shows change in IPSS total score. Silodosin shows a larger decrease in score compared to placebo over time.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 05)

A line graph comparing the change from baseline in Qmax (mL/sec) over time between placebo and Silodosin Capsules 8 mg. The x-axis represents days (Baseline, 1, 7, 14, 28, 84/LOCF), and the y-axis shows change in Qmax. Silodosin shows a greater increase than placebo throughout the period, with statistical significance indicated at p<0.05.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 06)

A line graph comparing change from baseline in Qmax (mL/sec) over days for Silodosin Capsules 8 mg versus placebo. The x-axis represents days (B, 1, 7, 14, 28, 84/LOCF) and the y-axis shows change in Qmax from baseline. Silodosin shows a consistently higher increase compared to placebo, with statistical significance indicated at day 84/LOCF (p<0.05).*

FDA Label Image

Label (Lbl721622447)

Silodosin Capsules 8 mg oral capsules packaging label showing the product name, strength, and quantity of 30 capsules. The label indicates it is relabeled by Bryant Ranch Prepack and manufactured by V-Ensure Pharma Technologies Pvt. Ltd. It includes storage instructions, dosage information, child-resistant packaging notice, and QR codes for additional prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.